Verifying…
Home / Drug A–Z / Salbutamol & Theophylline Tablet

Salbutamol & Theophylline Tablet

NAFDAC Reg. No. C4-1857 · Drug

Registered with NAFDAC. Registration activeAs of 28 October 2026 · synced automatically from official sources.
Product
Salbutamol & Theophylline Tablet
NAFDAC number
C4-1857
Active ingredient
Salbutamol (Salbutamol Sulfate); Theophylline
Strength
2 mg; 100 mg
Form
Tablet
Pack size
1 x 50's
Manufacturer
Not listed
Applicant (holder)
Nasajones Industries Ltd
Approved
28 Sep 2021
Status
Inactive View on NAFDAC ↗
Registration valid to
27 Sep 2026
WHO alerts
None found
Community reports
None
Times checked
0

What we found

  • Salbutamol & Theophylline Tablet is on the NAFDAC register with an active registration (C4-1857). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Salbutamol & Theophylline Tablet

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Who it is for

Albuterol tablets, USP are indicated for the relief of bronchospasm in adults and children 6 years of age and older with reversible obstructive airway disease.

How to take it and how often
  • The following dosages of albuterol tablets, USP are expressed in terms of albuterol base
  • Usual Dosage
  • Pediatric Patients 6 to 12 Years of Age: For
  • Pediatric patients 6 to 12 years of age, the usual dosage is 2 mg three or four times a day
  • Adults and
  • Pediatric Patients Over 12 Years of Age: For
  • Adults and
  • Pediatric patients over 12 years of age, the usual starting dosage is 2 or 4 mg three or four times a day
  • Dosage Adjustment
  • Pediatric Patients 6 to 12 Years of Age Who Fail to Respond to the Initial Starting Dosage of 2 mg Four Times a Day : For
  • Pediatric patients from 6 to 12 years of age who fail to respond to the initial starting dosage of 2 mg four times a day, the dosage may be cautiously increased stepwise, but not to exceed 24 mg/day (given in divided doses)
  • Adults and
  • Pediatric Patients Over 12 Years of Age: For
  • Adults and
Talk to a doctor first if

Albuterol tablets are contraindicated in patients with a history of hypersensitivity to albuterol, or any of their components.

Medicines it may not mix with

The concomitant use of albuterol tablets and other oral sympathomimetic agents is not recommended since such combined use may lead to deleterious cardiovascular effects. This recommendation does not preclude the judicious use of an aerosol bronchodilator of the adrenergic stimulant type in patients receiving albuterol tablets. Such concomitant use, however, should be individualized and not given on a routine basis. If regular co-administration is required, then alternative therapy should be considered. …

Warnings

Paradoxical Bronchospasm Albuterol tablets can produce paradoxical bronchospasm, which may be life threatening. If paradoxical bronchospasm occurs, albuterol tablets should be discontinued immediately and alternative therapy instituted. Deterioration of Asthma Asthma may deteriorate acutely over a period of hours, or chronically over several days or longer. If the patient needs more doses of albuterol tablets than usual, this may be a marker of destabilization of asthma and requires re-evaluation of the patient and the treatment regimen, giving special consideration to the possible need for anti-inflammatory treatment, e.g., corticosteroids. …

Possible side effects

The adverse reactions to albuterol are similar in nature to those of other sympathomimetic agents. Albuterol Tablets Adverse Experience Incidence (% of patients) in Adults and Children 6 Years of Age and Older Adverse Event Percent Incidence Central nervous system Nervousness 20 Tremor 20 Headache 7 Dizziness 2 Weakness 2 Sleeplessness 2 Irritability < 1 Drowsiness < 1 Restlessness < 1 Cardiovascular Palpitations 5 Tachycardia 5 Flushing < 1 Chest discomfort < 1 Musculoskeletal Muscle cramps 3 Gastrointestinal Nausea 2 Genitourinary Difficulty in micturition < 1 Albuterol Extended-release Tablets Incidence of Adverse Reactions (% of Patients) in a 1-week Clinical Trials* Adverse Event Albute …

If you take too much

The expected symptoms with overdosage are those of excessive beta-adrenergic stimulation and/or occurrence or exaggeration of any of the symptoms listed under ADVERSE REACTIONS , e.g., angina, hypertension tachycardia with rates up to 200 beats per minute, nervousness, headache, tremor, dry mouth, palpitation, nausea, dizziness, and insomnia. In addition, seizures, hypotension, arrhythmias, fatigue, malaise and hypokalemia may also occur. As with all sympathomimetic medications, cardiac arrest and even death may be associated with abuse of albuterol tablets. …

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2026-04-14.

Label for salbutamol (salbutamol sulfate) and theophylline, the active ingredient registered with NAFDAC.

Check your pack of Salbutamol & Theophylline Tablet

Add the expiry date on your pack for a full Trust Score.

3 free checks left today Official sources: NAFDAC · WHO · U.S. FDA · Health Canada · NLM

About Salbutamol & Theophylline Tablet

What is in Salbutamol & Theophylline Tablet?

Salbutamol & Theophylline Tablet contains Salbutamol (Salbutamol Sulfate); Theophylline (2 mg; 100 mg), as tablet, according to its NAFDAC registration record.

Is Salbutamol & Theophylline Tablet registered with NAFDAC?

Yes. Salbutamol & Theophylline Tablet is listed on the NAFDAC register under registration number C4-1857, and its registration is active as of 28 October 2026.

Has Salbutamol & Theophylline Tablet been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Salbutamol & Theophylline Tablet in our automatically synced alert list.

How can I check that my pack of Salbutamol & Theophylline Tablet is genuine?

Run a free authenticity scan with the NAFDAC number C4-1857, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Salbutamol & Theophylline Tablet?

Follow your prescription or the leaflet in your pack. The official label says: The following dosages of albuterol tablets, USP are expressed in terms of albuterol base. Usual Dosage Pediatric Patients 6 to 12 Years of Age: For pediatric patients 6 to 12 years of age, the usual dosage is 2 mg three or four times a day. Adults and Pediatric Patients Over 12 Years of Age: For adults and pediatric patients over 12 years of age, the usual starting dosage is 2 …

What is Salbutamol & Theophylline Tablet used for?

Albuterol tablets, USP are indicated for the relief of bronchospasm in adults and children 6 years of age and older with reversible obstructive airway disease. (Summarised from the official U.S. FDA label for salbutamol (salbutamol sulfate) and theophylline. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Salbutamol & Theophylline Tablet? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.